Smart MoneySmart Money

Andrew Bascand: Investing in new technology

View descriptionShare

Andrew Bascand, Managing Director of Harbour Asset Management joins me to discuss new findings of the GLP-1 drug class, which has predominantly been used to treat type 2 diabetes but has captured notable mindshare with healthcare specialists and macro investors.

Listen in for your chance to get ahead of the markets.

LISTEN ABOVE

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Smart Money

Looking to make sense of your dollars? Newstalk ZB’s Smart Money delves into the deep, dark recesses 
Social links
Follow podcast
Recent clips
Browse 324 clip(s)